Co‐existence of BRAF V600E ‐mutated malignant melanoma and BRAF V600E‐mutated Langerhans cell histiocytosis: A case report
- 18 November 2021
- journal article
- research article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 49 (4) , 393-398
Abstract
Langerhans cell histiocytosis (LCH) is a neoplastic condition of Langerhans cells, and can be associated with other neoplasms, especially BRAF-mutant hematological tumors and papillary thyroid carcinoma. Here we present the first case of co-existing LCH and low cumulative sun damage (low-CSD) melanoma, both of which had a BRAF V600E mutation. A 49-year-old man had a 45 × 43 × 15 mm semi-pedunculated, pigmented tumor in his back but had no other systemic symptoms. Histopathology revealed a 2-mm-sized incidental focus of LCH within a large lesion of low-CSD melanoma. Diffuse immunoexpression of CD1a, langerin/CD207, S100 protein, and BRAF (VE1) was observed in the focus of LCH. Sanger sequencing with microdissection confirmed BRAF V600E mutation in the component of LCH. Interestingly, the advanced melanoma also harbored the same BRAF V600E mutation, although the significance of this tumor combination is still unknown.Keywords
This publication has 37 references indexed in Scilit:
- Langerhans cell histiocytosis first presenting in the skin in adults: frequent association with a second haematological malignancyBritish Journal of Dermatology, 2012
- Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndromeClinical Genetics, 2011
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- GermlineBRAFmutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrumHuman Mutation, 2009
- Spontaneous Regression of Langerhans Cell Histiocytosis in a Neonate With Multiple Bony LesionsJournal of Pediatric Hematology/Oncology, 2008
- Aggressive Langerhans cell histiocytosis following T‐ALL: Clonally related neoplasms with persistent expression of constitutively active NOTCH1American Journal of Hematology, 2007
- Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndromeNature Genetics, 2006
- BRAF mutation in thyroid cancerEndocrine-Related Cancer, 2005
- BRAF mutations in papillary carcinomas of the thyroidOncogene, 2003
- SPONTANEOUS REMISSION OF MULTI-SYSTEM HISTIOCYTOSIS XThe Lancet, 1984